
Skin Grafting System Market Report 2026
Global Outlook – By Product (Dermatomes, Wound Debridement Devices, Skin Graft Mesher Equipment, Accessories, Other Products), By Graft Source (Autograft, Allograft), By Wound Type (Burns, Chronic Wounds, Surgical Wounds, Traumatic Wounds, Other Wound Types), By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Skin Grafting System Market Overview
• Skin Grafting System market size has reached to $1.14 billion in 2025 • Expected to grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Impact Of Rising Burn Injury Prevalence On The Skin Grafting System Market • Market Trend: Innovative Biologic Grafts Combine Fish Skin And Silicone To Accelerate Wound Healing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Skin Grafting System Market?
A skin grafting system is a medical apparatus used to remove and apply skin grafts for the treatment of wounds, burns, or other skin defects. This system typically includes tools which are used to remove thin layers of skin from donor sites, and devices to apply and secure the graft to the recipient area. The purpose of a skin grafting system is to facilitate the transplantation of healthy skin to damaged areas, promoting healing, and restoring the skin's appearance and function. The main skin grafting systems include dermatomes, wound debridement devices, skin graft mesher equipment, accessories, and others. It can be used for both autografts and allografts, and it is used for various types of wounds such as burns, chronic wounds, surgical wounds, traumatic wounds, and others. It is used by several end users, including ambulatory surgical centers, hospitals, and specialty clinics.
What Is The Skin Grafting System Market Size and Share 2026?
The skin grafting system market size has grown strongly in recent years. It will grow from $1.14 billion in 2025 to $1.23 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing incidence of burn injuries, rising number of surgical procedures, expansion of specialized wound care centers, availability of autograft techniques, growing adoption of mechanical debridement devices.What Is The Skin Grafting System Market Growth Forecast?
The skin grafting system market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing demand for advanced wound management solutions, rising focus on faster healing outcomes, expansion of reconstructive and plastic surgeries, growing investments in biologic graft technologies, increasing adoption of minimally invasive grafting systems. Major trends in the forecast period include increasing adoption of advanced dermatomes, rising use of powered skin graft meshers, growing demand for biologic skin substitutes, expansion of burn and trauma care procedures, enhanced focus on precision wound treatment.Global Skin Grafting System Market Segmentation
1) By Product: Dermatomes, Wound Debridement Devices, Skin Graft Mesher Equipment, Accessories, Other Products 2) By Graft Source: Autograft, Allograft 3) By Wound Type: Burns, Chronic Wounds, Surgical Wounds, Traumatic Wounds, Other Wound Types 4) By End User: Ambulatory Surgical Centers, Hospitals, Specialty Clinics Subsegments: 1) By Dermatomes: Hand-Held Dermatomes, Powered Dermatomes, Air-Driven Dermatomes, Electric Dermatomes 2) By Wound Debridement Devices: Surgical Debridement Devices, Mechanical Debridement Devices, Autolytic Debridement Devices, Enzymatic Debridement Devices 3) By Skin Graft Mesher Equipment: Manual Skin Graft Meshers, Powered Skin Graft Meshers 4) By Accessories: Grafting Blades And Replacement Parts, Grafting Sheets And Templates, Bandages And Dressings, Surgical Trays And Containers 5) By Other Products: Skin Graft Storage Solutions, Cryopreservation Equipment, Biologic Skin Substitutes (Artificial Skin), Skin Graft ImplantsWhat Is The Driver Of The Skin Grafting System Market?
The rising prevalence and occurrences of burn injuries are expected to propel the growth of the skin grafting system market going forward. Burn injuries refer to damage to the skin or deeper tissues caused by heat, chemicals, electricity, sunlight, or radiation. The increasing occurrences of burn injuries can be attributed to factors such as residential fires, industrial accidents, chemical exposures, electrical mishaps, and natural disasters. The advancements in skin grafting systems enhance the treatment of burn injuries by facilitating precise grafting procedures, thereby promoting effective wound healing, and improving patient outcomes in burn care facilities. For instance, in November 2024, according to the Llywodraeth Cymru, a UK-based Welsh government, From 2023 to 2024, there were 18 fatal casualties from fires in Wales, marking an increase of 4 compared to 2022–23. During the same period, there were also 366 non-fatal fire-related casualties. Therefore, a rising prevalence and occurrence of burn injuries is driving the skin grafting system industry.Key Players In The Global Skin Grafting System Market
Major companies operating in the skin grafting system market are Johnson And Johnson Services Inc., Stryker Corporation, B. Braun Melsungen AG, Smith And Nephew Plc, Integra LifeSciences Holdings Corporation, ConvaTec Group Plc, Molnlycke Health Care AB, Kinetic Concepts Inc., Aesculap Inc., Organogenesis Inc., MiMedx Group Inc., Polynovo Ltd., Avita Medical, Tissue Regenix Group Plc, Osiris Therapeutics Inc., Exsurco Medical Inc., Rudolf Storz GmbH, Lohmann And Rauscher, De Soutter Medical Ltd., Nouvag AGGlobal Skin Grafting System Market Trends and Insights
Major companies operating in the skin grafting system market are increasingly focusing on developing innovative biologic grafts, such as silicone‑fish‑skin composite grafts, to enhance wound healing, reduce infection risk, and improve graft integration compared to traditional skin grafts. Silicone‑fish‑skin composite grafts are wound‑covering materials that combine fish-derived skin, rich in collagen and growth factors, with a silicone layer to protect the wound and promote faster, more effective healing than conventional grafts. For instance, in December 2024, Kerecis Limited, a US-based medical device company, launched SurgiClose Silicone, a new product that combines a fish-skin graft with a silicone backing specifically designed for the treatment of surgical and trauma wounds. These silicones offer a breakthrough combination of an intact, fenestrated fish skin graft and a highly refined, breathable silicone contact layer that supports tissue regeneration and optimal wound moisture management. The product simplifies surgical workflows by integrating the fish skin and silicone backing into one bilayer device, eliminating the need for additional supporting products like separate wound dressings or contact layers. Its gentle processing preserves the natural structure, mechanical properties, and essential molecules of the fish skin, making it homologous to human skin and effective for managing surgical, trauma, and acute wounds in the operating room.What Are Latest Mergers And Acquisitions In The Skin Grafting System Market?
In August 2023, Coloplast A/S, a Denmark-based medical device manufacturing company, acquired Kerecis for an undisclosed amount. The aim of the acquisition of Kerecis by Coloplast is to enhance Coloplast's wound care offerings by integrating Kerecis' innovative biologic wound care technology, based on intact fish skin, into its portfolio. This acquisition aims to provide advanced wound treatment solutions, drive long-term growth, improve profitability, and expand Coloplast's presence in the biologics segment, particularly in the US market. The acquisition is expected to leverage Kerecis' strong commercial presence and clinical evidence to help more patients and achieve significant value creation for Coloplast. Kerecis is an Iceland-based manufacturer of fish skin-based therapeutic grafting products.Regional Outlook
North America was the largest region in the skin grafting system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Skin Grafting System Market?
The skin grafting system market consists of sales of graft carriers, and skin graft knives that help with the removal, preparation, and application of skin grafts. These tools facilitate precise cutting, expansion of grafts, and proper handling to ensure successful transplantation and healing of damaged skin areas. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Skin Grafting System Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.23 billion |
| Revenue Forecast In 2035 | $1.63 billion |
| Growth Rate | CAGR of 7.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Graft Source, Wound Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson And Johnson Services Inc., Stryker Corporation, B. Braun Melsungen AG, Smith And Nephew Plc, Integra LifeSciences Holdings Corporation, ConvaTec Group Plc, Molnlycke Health Care AB, Kinetic Concepts Inc., Aesculap Inc., Organogenesis Inc., MiMedx Group Inc., Polynovo Ltd., Avita Medical, Tissue Regenix Group Plc, Osiris Therapeutics Inc., Exsurco Medical Inc., Rudolf Storz GmbH, Lohmann And Rauscher, De Soutter Medical Ltd., Nouvag AG |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
